Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hanwha Group

www.hanwha.co.kr

Latest From Hanwha Group

Biologics World Korea: Counting On A Paradigm Shift In Biologics Market

Biopharmaceutical experts from around the world gathered in Seoul at the recent Biologics World Korea 2015, at which a group of panelists discussed the strategic direction of the biologics industry in Asia and a paradigm shift in the global biologics market.

BioPharmaceutical South Korea

Samsung Biosimilar Lantus Filings Planned As Pipeline Progresses

Samsung's biosimilar projects seem to be progressing smoothly, with its affiliate Samsung Bioepis in the final stage of a Phase III global clinical study for SB9, its biosimilar version of Sanofi's blockbuster Lantus (insulin glargine), for which an approval filing is planned in the U.S. in the latter half of this year and in Europe early next year.

BioPharmaceutical South Korea

Samsung Prepping For First Biosimilar Launch

Samsung Bioepis' biosimilar version of Amgen's rheumatoid arthritis blockbuster Enbrel (etanercept) is set to become the firm’s first biosimilar product to hit the market, possibly being released in South Korea late this year and in Europe in the first half of next year.

BioPharmaceutical North Korea

Samsung Prepping For First Biosimilar Launch

Samsung Bioepis's biosimilar version of Amgen's rheumatoid arthritis blockbuster Enbrel (etanercept) is set to become the firm’s first biosimilar product to hit the market, possibly being released in South Korea late this year and in Europe in the first half of next year.

BioPharmaceutical South Korea
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Hanwha Group
  • Senior Management
  • Seung-Youn Kim, CEO
  • Contact Info
  • Hanwha Group
    Phone: (82) 2 729 1881
    1 Janggyo-dong
    Jung-gu, 100-797
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register